Company: ZVRA
Filing Date: 2025-03-31
Form Type: PREC14A
Source: 0001193125-25-068746
Chunk: 4

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: PREC14A
Chunk 4
---
 on Form 10-K for the year ended December 31, 2024, and our other filings with the Securities and Exchange Commission (the “SEC”). Other unknown or unpredictable factors also could have material adverse effects on our future results, performance or achievements. In light of these risks, uncertainties, assumptions and factors, the forward-looking events discussed herein may not occur. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date stated, or if no date is stated, as of the date hereof. The Company does not undertake any obligation to publicly update or revise any forward-looking statements because of new information, future events or otherwise. 5

FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD VIRTUALLY ON [ ● ], 2025, AT [ ● ] EASTERN TIME ZEVRA THERAPEUTICS, INC. 1180 Celebration Boulevard, Suite 103 Celebration, FL 34747 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING WHY DID I RECEIVE THESE PROXY MATERIALS? The Board of Directors (the “Board”) of Zevra Therapeutics, Inc. (sometimes referred to as “us,” “we,” the “Company” or “Zevra”) is soliciting your proxy to vote at the Company’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”), including at any continuation, adjournments or postponements of the Annual Meeting. These proxy materials also include a WHITEproxy card for the Annual Meeting. WHITEproxy cards are being solicited on behalf of the Board. The Company’s proxy materials include detailed information about the matters that will be discussed and voted on at the Annual Meeting and provide updated information about the Company that you should consider in order to make an informed decision when voting your shares. We intend to mail these proxy materials on or about [ ●], 2025 to all stockholders of record entitled to vote at the Annual Meeting. WHAT AM I VOTING ON? The following matters scheduled for a vote:

| • |     | Election of two Class I directors to the Company’s Board to hold office until the 2028 annual meeting of stockholders, and until their respective successors shall have been duly elected and qualified (Proposal 1); and |

6

WHAT ARE THE BOARD’S VOTING RECOMMENDATIONS? The Board recommends that you vote your shares as follows by using the enclosed WHITEproxy card and returning it in